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Case Report
Bilateral Renal Choriocarcinoma in a Postmenopausal Woman
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Choriocarcinoma is the most malignant tumor of gestational trophoblastic neoplasia. 
It grows rapidly and metastasizes to the lung, liver, and less frequently, the brain. 
Metastases to the kidney are rare in the literature, and bilateral involvement is even 
more scarce. Renal involvement of choriocarcinoma is highly exceptional and may mim-
ic renal cell carcinoma. Here we report a case of bilateral renal choriocarcinoma present-
ing 5 years after a history of a total anterior hysterectomy because of a hydatidiform 
mole.
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Choriocarcinomas are rare, highly malignant trophoblas-
tic tumors that are usually encountered after a pregnancy 
in the uterus. They are composed of two types of cells, syncy-
tiotrophoblasts, the differentiated hormone-secreting com-
ponent, and cytotrophoblasts [1]. Nongestational chorio-
carcinomas are believed to develop from pluripotent germ 
cells, most commonly arising in the gonads. Gestational 
choriocarcinoma is a rare complication of pregnancy with 
an incidence of 1 in 20,000 to 25,000 in Western countries. 
It arises from a prior molar pregnancy or rarely a nonmolar 
gestation within 1 year of the antecedent pregnancy [2]. 
Choriocarcinoma in postmenopausal women is very rare; 
however, a few cases of choriocarcinoma that developed af-
ter a long latent period from a previous pregnancy have 
been reported [2,3]. The most frequent sites of metastases 
are pulmonary and vaginal, but other abdominal viscera 
and the brain may also be affected, and renal involvement 
is rare [4]. Herein we report a case of renal choriocarcinoma 
in a postmenopausal woman with bilateral renal masses, 
15 years after her last pregnancy and 5 years after a history 
of total anterior hysterectomy because of a hydatidiform 
mole.
CASE REPORT
A 50-year-old female presented to the emergency depart-
ment with complaints of weakness, right lumbar pain, and 
painless total hematuria. She had lost 20 kg of weight in 
the past 2 months and her hematuria had been present for 
the past month with no history of trauma. The physical ex-
amination was unremarkable except for increased sensi-
tivity on her right flank and hemoglobin and hematocrit 
values of 6.9 mg/dl and 20%, respectively. Owing to clot re-
tention, continuous bladder irrigation was initiated and 
her hemoglobin levels were corrected with transfusions. 
Abdominal ultrasonography revealed bilateral renal 
masses. Computed tomography (CT) scans of the chest, ab-
domen, and pelvis showed a 9 cm cystic renal mass on the 
right and another 5 cm tumor on the left kidney; a sub-
pleural 5 cm lesion was visible on the right lower lobe of the 
lung CT (Fig. 1, 2). Bone scans showed no evidence of 
metastasis. An ultrasound-guided tru-cut biopsy of the 
right kidney was performed with a pathologic diagnosis of 
xanthogranulomatous pyelonephritis. Fine-needle aspi-
ration biopsy of the lung lesion was reported as the coagu-
lation type of necrosis. After cystoscopic evaluation to dis-
close the source of the hematuria, right transperitoneal 
radical nephrectomy was performed. The surgery was un-
complicated except for a 3 cm tear in the vena cava that was 
primarily sutured. 
　On the first postoperative day an increase in serum bilir-
ubin levels was detected and the patient developed tachyp-
nea and dyspnea. A repeat CT scan of the chest and abdo-
men demonstrated multiple lesions in the liver and spleen 
that were not visible on the preoperative scans, with an in-
crease in size and number of the lesions in the lung. The 
patient’s recovery period was troublesome and extended; 
nevertheless, no further surgical intervention was nece-Korean J Urol 2011;52:498-501
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FIG. 1. Abdominal CT scan showing bi-
lateral renal masses.
FIG. 2. Peripheral nodular lesions on 
both lungs (black arrows).
ssary. The pathologic report of the removed kidney was 
pure choriocarcinoma (Fig. 3); assessment of the serum be-
ta-human chorionic gonadotropin level was over 1 million 
mIU/ml. The final diagnosis was gestational choriocarci-
noma, and the patient was referred to the oncology depart-
ment for methotrexate-based chemotherapy following sta-
bilization of her general status.
DISCUSSION
Nongestational choriocarcinoma can arise from germ cell 
or trophoblastic differentiation within endometrial carci-
nomas. Gestational choriocarcinomas are mostly seen in 
women of reproductive age, generally within 1 year after 
a molar or nonmolar pregnancy. The risk of developing cho-
riocarcinoma is exceptional before 20 years of age but in-
creases significantly from 40 years onward. Nearly 30% of 
patients with choriocarcinoma present with metastasis on 
diagnosis. The tumor has a tendency to disseminate hema-
togenously. Lung, vagina, and brain metastasis occurs in 
50%, 30%, and 10% of cases, respectively; liver and kidney 
metastasis is less common [5]. Urological involvement with 
gestational trophoblastic neoplasia is relatively rare, but 
renal involvement may cause massive retroperitoneal he-Korean J Urol 2011;52:498-501
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morrhage [4]. Renal metastases can cause abdominal pain, 
hematuria, or oliguria but are more usually found as in-
cidental mass lesions during radiological staging.
　According to the International Society for the Study of 
Trophoblastic Disease, the incidence of renal metastases 
from choriocarcinoma is rare and can result in perinephric 
hemorrhage and lead to spontaneous rupture. Renal in-
volvement can also present with hematuria [6]. The case 
we reported here presented with gross hematuria originat-
ing from the right kidney that was confirmed by cystoscopic 
evaluation. Additionally, no evidence of other metastasis 
was determined except for the lesion in the lung, which 
could not be diagnosed by fine-needle biopsy. Wang et al 
reported that renal metastases were invariably preceded 
by lung metastasis (100%), indicating that renal meta-
stasis is most likely the result of dissemination of tumor 
cells through the general circulation secondary to lung 
metastasis [7]. However, this seems not to have been the 
case in our patient, in whom dissemination of lung meta-
stases occurred after radical nephrectomy.
　Choriocarcinoma is preceded by a hydatidiform mole 
60% of cases, by previous miscarriages in 23%, by full-term 
pregnancy in 10%, and is primary in 5% of cases. Our case 
had a choriocarcinoma with a history of a hydatidiform 
mole 5 years previously. 
　The International Federation of Gynecology and Obste-
trics (FIGO) staging for trophoblastic diseases that was de-
vised in 1992 was improved in 2002 by combining the basic 
anatomic staging with the modified WHO risk factor scor-
ing system [8]. The diagnosis and treatment of choriocarci-
noma is based on the biological behavior of the tumor rather 
than a histopathological diagnosis. The histological chorio-
carcinoma does not add to the risk score by the FIGO sys-
tem. Use of the FIGO staging system is essential in deter-
mining initial therapy for patients with gestational tropho-
blastic neoplasia to ensure the best possible outcomes with 
the least morbidity. Our case was staged as IV: 20 according 
to the FIGO 2002 scoring system.
　Patients with high-risk metastatic gestational tropho-
blastic neoplasia (FIGO stage IV and stages II-III score 7) 
should be treated initially with multiagent chemotherapy 
with or without adjuvant surgery or radiation therapy [9]. 
Multiagent chemotherapy, a combination of etoposide, 
high-dose methotrexate with folinic acid, actinomycin D, 
cyclophosphamide, and vincristine (EMA-CO), results in 
improved remission and survival rates. Virtually 50% of 
FIG. 3. Histological sections showing. (A) H&E (x10), (B) Inhibin
staining of syncytiotrophoblasts (x20), (C) Tumor cells stained 
with b-hcg (x10).Korean J Urol 2011;52:498-501
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high-risk patients require surgical treatment during the 
course of treatment [10].
　In conclusion, this case demonstrates that metastatic 
choriocarcinoma can present with flank pain, hematuria, 
and a renal mass imitating renal cell carcinoma. Also inter-
esting in our case was the occurrence of bilateral renal 
masses followed by disseminated multi-organ metastases 
at 5 years after a hydatidiform mole treated with total ab-
dominal hysterectomy and bilateral salpingo-oophorec-
tomy. The patient was referred to medical oncology after 
the right radical nephrectomy and is still undergoing a che-
motherapy protocol.
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